Opto Circuits (India) has suffered another major setback during the year ended March 2016 as its consolidated net sales declined by 73.7 per cent to Rs.311.59 crore from Rs.1186.80 crore in the previous year. Its net loss for the year declined to Rs.2.43 crore as against Rs.156.37 crore. Its EPS worked out to negative Rs.0.10 as compared to negative Rs.6.45 in the last year. International sales amounted to Rs.299.22 crore and its domestic sales reached at Rs.47.56 crore.

The poor performance reflected in the share price movement. Its Rs.10 each equity share is currently quoted at Rs.9.92 on BSE. The share reached its yearly highest level at Rs.22.8 and lowest at Rs.8.12.

Its subsidiary Cardiac Science Corporation was taken over by CFS through a sale by a secured lender, viz DBS Bank. Opto Circuits is seeking appropriate legal recourse in US courts to protect the interest of shareholders. The company got back Criticare Systems Inc, USA.

Its equity capital stood at Rs.242.32 crore. Its reserves & surplus declined to Rs.1,446 crore from Rs.1,710 crore in the previous year. Currently, promoters are holding 28.28 per cent equity shares and 34.10 per cent is with public.